Brazil has overtaken the United States among major agricultural exporters as having the shortest time for these products in the regulatory process.

Astounding advances in recent years in the natural sciences and biotechnology has put us at the dawn of a "bio-economy." Life-sustaining scientific advances and significant economic opportunities will go hand-and-glove in this economy. Unfortunately, U.S. regulatory policies are not keeping up with science and political leadership is needed to turn back ideological and unfounded fears about the risks associated with biotechnology and innovations in life sciences. The United States' comparative advantage in this cutting-edge field could be at risk if we fail to align our regulatory practices with the speed of today's breakthroughs.